D221 Task 1 Practice Improvement Plan for Medication Safety

Student Name

Western Governors University 

D221 Organizational Systems and Healthcare Transformation

Prof. Name

Date

D221 Task 1 Practice Improvement Plan for Medication Safety

Discuss a System-Level Safety Concern in a Healthcare Setting Using SBAR Format

Situation

Medication administration is a core clinical responsibility of bedside nurses and requires precision, vigilance, and strict adherence to safety protocols. This process encompasses accurate medication dispensing, confirmation of patient identity, assessment of allergies and potential drug–drug interactions, and ongoing monitoring for adverse drug reactions. Despite established safeguards, medication errors continue to pose a significant threat to patient safety across healthcare settings. Current evidence indicates that medication-related errors contribute to thousands of preventable deaths each year in the United States and result in numerous nonfatal adverse events that often go underreported (Tariq et al., 2023). Beyond patient harm, these errors negatively influence staff morale, erode patient trust, and damage organizational credibility. Addressing medication safety at the system level is therefore essential to improving patient outcomes and sustaining public confidence in healthcare delivery.

Background

What Data Supports the Need for Change?

Medication errors remain one of the most prevalent and costly categories of medical mistakes. An estimated 1.5 million individuals are affected annually, leading to substantial morbidity and avoidable utilization of healthcare resources (Grissinger, 2019). Direct hospital expenditures associated with medication-related injuries exceed $3.5 billion per year, while the broader economic burden—including lost productivity and long-term care—has been estimated at approximately $77 billion annually. Patient-reported data further underscore the scope of the problem, with a significant proportion of Americans indicating personal experience with medication errors. These data clearly demonstrate the urgency for system-level interventions aimed at reducing preventable medication-related harm.

What Are the Relevant National Patient Safety Standards?

The Joint Commission’s National Patient Safety Goals establish clear expectations for safe medication practices. Two standards are particularly relevant to this improvement initiative: accurate patient identification and safe medication administration. Nurses are required to verify patient identity using at least two approved identifiers, such as name, date of birth, or medical record number, prior to administering medications. In addition, reviewing documented allergies, assessing potential contraindications, and confirming the correct medication, dose, route, and timing are mandatory practices designed to minimize adverse events and ensure regulatory compliance.

Assessment

What Is the Impact of Medication Errors on Patients and the Healthcare Setting?

Medication errors undermine the foundational trust patients place in healthcare professionals and institutions. For patients, these errors may result in physical injury, prolonged hospitalization, emotional distress, and decreased confidence in care providers. From an organizational perspective, medication errors increase financial strain through extended lengths of stay, regulatory penalties, and legal exposure. Clinicians and nursing staff are also affected, as involvement in medication errors is associated with heightened stress, professional repercussions, and decreased job satisfaction.

Recommendation

What Evidence-Based Changes Are Proposed?

The implementation of Electronic Medication Administration Records (eMAR) in conjunction with Barcode Medication Administration (BCMA) is recommended as a primary strategy to reduce medication errors. These technologies support high-reliability practices by automating verification steps, standardizing documentation, and providing real-time clinical decision support. Evidence demonstrates that the integration of eMAR and BCMA significantly reduces medication administration error rates and improves adherence to safety protocols (Truitt et al., 2016). In addition to enhancing accuracy, these systems improve workflow efficiency and promote accountability among healthcare providers.

What Barriers Could Hinder Implementation?

How Can These Barriers Be Addressed?

To mitigate implementation challenges, healthcare organizations should invest in structured and ongoing education programs that ensure staff competency with eMAR and BCMA systems. Training should include simulation-based learning and periodic refresher sessions to reinforce best practices. In emergency scenarios, clearly defined protocols and readily accessible crash carts stocked with essential medications can ensure timely care without bypassing safety checks. Leadership support and continuous feedback mechanisms are also critical to sustaining long-term compliance.

Why Is Shared Decision-Making Important?

Shared decision-making among administrators, nurses, pharmacists, and information technology professionals fosters collaboration and strengthens ownership of safety initiatives. Engaging frontline staff in planning and evaluation increases acceptance of system changes and reduces resistance to new workflows. Financially, reducing medication errors has the potential to save healthcare organizations millions of dollars annually, allowing reinvestment in staff development, advanced technologies, and quality improvement initiatives that further enhance patient care (NIH, 2020).

Outcome Measurement

The effectiveness of the proposed interventions can be evaluated by comparing medication error incident reports before and after the implementation of eMAR and BCMA. Additional metrics may include compliance with barcode scanning, rates of near-miss events, and staff satisfaction with medication administration workflows. A sustained reduction in reported errors would indicate successful improvement in medication safety.

Current Care Delivery Model

The current care delivery approach is based on a functional nursing model, in which tasks are divided among staff members rather than assigned to a single nurse responsible for comprehensive patient care. While this model may improve efficiency, it can also fragment communication and reduce continuity of care. Parreira et al. (2021) note that functional models may limit individualized assessment and coordination, increasing the risk of errors during complex processes such as medication administration.

Impact of Recommended Change on the Care Delivery Model

Integrating eMAR and BCMA into the functional nursing model is expected to enhance communication, standardize medication workflows, and reduce variability in practice. These technologies support real-time information sharing among team members, thereby decreasing the likelihood of omissions and duplications. Over time, improved accuracy and transparency in medication administration can strengthen nurse–patient relationships, improve clinical outcomes, and enhance the organization’s overall reputation for safety and quality.

Summary Table: SBAR for Medication Safety Concern

References

Grissinger, M. (2019). Medication errors. AMCP.org. https://www.amcp.org/about/managedcare-pharmacy-101/concepts-managed-care-pharmacy/medication-errors

National Institutes of Health. (2020). Medical errors and patient safety. National Library of Medicine. https://www.ncbi.nlm.nih.gov/

Parreira, P., Santos-Costa, P., Neri, M., Marques, A., Queirós, P., & Salgueiro-Oliveira, A. (2021). Work methods for nursing care delivery. International Journal of Environmental Research and Public Health, 18(4), 2088. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924841/

Tariq, R. A., Scherbak, Y., Sinha, A., & Vashisht, R. (2023). Medication dispensing errors and prevention. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK519065/

Truitt, E., Thompson, R., Blazey-Martin, D., NiSai, D., & Salem, D. (2016). Effect of the implementation of barcode technology and an electronic medication administration record on adverse drug events. Hospital Pharmacy, 51(6), 474–483. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911988/